My bookmarksSign up free
Source

Commission Regulation (EU) 2018/221 of 15 February 2018 amending Regulation (EC) No 999/2001 of the European Parliament and of the Council and Regulation (EC) No 882/2004 of the European Parliament and of the Council as regards the European Union reference laboratory for transmissible spongiform encephalopathies (Text with EEA relevance. )

Commission Regulation (EU) 2018/221 of 15 February 2018 amending Regulation (EC) No 999/2001 of the European Parliament and of the Council and Regulation (EC) No 882/2004 of the European Parliament and of the Council as regards the European Union reference laboratory for transmissible spongiform encephalopathies (Text with EEA relevance. )

Regulation (EU) 2018/221 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

In Chapter B of Annex X to Regulation (EC) No 999/2001, point 1 is replaced by the following: ‘1. The EU reference laboratory for TSEs is a consortium between the Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta (IZSPLVA) and the Istituto Superiore di Sanità (ISS), led by IZSPLVA:   Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta (IZSPLVA) Via Bologna 148 10154 Torino Italy   Istituto Superiore di Sanità (ISS) Viale Regina Elena 299 00161 Roma Italy’.

Article 2

Open ↗

In Part I of Annex VII to Regulation (EC) No 882/2004, point 13 is replaced by the following: ‘13. EU reference laboratory for transmissible spongiform encephalopathies (TSEs) The laboratory referred to in point 1 of Chapter B of Annex X to Regulation (EC) No 999/2001’.

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 January 2019.

Other acts of the same type
Commission Regulation (EU) 2026/361 of 19 February 2026 amending Regulation (EU) No 582/2011 as regards the emissions type-approval of heavy-duty vehicles with on-board fuel and energy consumption monitoring devicesCommission Implementing Regulation (EU) 2026/366 of 19 February 2026 making imports of sodium benzoate originating in the People’s Republic of China subject to registrationCommission Implementing Regulation (EU) 2026/367 of 19 February 2026 amending Implementing Regulation (EU) 2019/2030 as regards administrative changes to the Union authorisation of the biocidal product family PAL IPA PRODUCT FAMILYCommission Implementing Regulation (EU) 2026/425 of 19 February 2026 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for Canada, the United Kingdom and the United States in the lists of third countries, territories, or zones thereof authorised for the entry into the Union of consignments of poultry and germinal products of poultry, and of fresh meat of poultry and game birdsCommission Implementing Regulation (EU) 2026/351 of 18 February 2026 renewing the approval of the active substance spinosad in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2026/352 of 18 February 2026 concerning the authorisation of L-arginine produced with Escherichia coli CCTCC M 20231961 as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2026/353 of 18 February 2026 concerning the authorisation of L-histidine and L-histidine monohydrochloride monohydrate, produced with Corynebacterium glutamicum KCCM 80389, as feed additives for all animal speciesCommission Implementing Regulation (EU) 2026/355 of 18 February 2026 renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2026/356 of 18 February 2026 concerning the authorisation of a preparation of endo-1,4-beta-xylanase produced with Bacillus subtilis LMG S-15136 as a feed additive for gestating sows (holder of authorisation: Puratos NV)Commission Implementing Regulation (EU) 2026/357 of 18 February 2026 amending Implementing Regulation (EU) 2023/2200 as regards administrative changes to the Union authorisation of the biocidal product family HCl Disinfecting Toilet Bowl CleanerCommission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-olCommission Implementing Regulation (EU) 2026/400 of 18 February 2026 granting a Union authorisation for the biocidal product family CHLOROCRESOL BASED PRODUCTS-CID Lines NV in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next